An observational study evaluating the safety and tolerability of regadenoson, in patients referred for single photon emission computed tomography myocardial perfusion imaging

Trial Profile

An observational study evaluating the safety and tolerability of regadenoson, in patients referred for single photon emission computed tomography myocardial perfusion imaging

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Apr 2017

At a glance

  • Drugs Regadenoson (Primary)
  • Indications Coronary disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 17 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top